Literature DB >> 25586397

The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery.

Judith A Pratt1, Brian J Morris2.   

Abstract

The thalamus (comprising many distinct nuclei) plays a key role in facilitating sensory discrimination and cognitive processes through connections with the cortex. Impaired thalamocortical processing has long been considered to be involved in schizophrenia. In this review we focus on the thalamic reticular nucleus (TRN) providing evidence for it being an important communication hub between the thalamus and cortex and how it may play a key role in the pathophysiology of schizophrenia. We first highlight the functional neuroanatomy, neurotransmitter localisation and physiology of the TRN. We then present evidence of the physiological roles of the TRN in relation to oscillatory activity, cognition and behaviour. Next we discuss the role of the TRN in rodent models of risk factors for schizophrenia (genetic and pharmacological) and provide evidence for TRN deficits in schizophrenia. Finally we discuss new drug targets for schizophrenia in relation to restoring TRN circuitry dysfunction.
© The Author(s) 2015.

Entities:  

Keywords:  GABA; Mental illness; NMDA receptor; drug discovery; genetics; schizophrenia; thalamic reticular nucleus; thalamus

Mesh:

Year:  2015        PMID: 25586397     DOI: 10.1177/0269881114565805

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  27 in total

Review 1.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

2.  Developmental expression of mGlu2 and mGlu3 in the mouse brain.

Authors:  Caitlin E McOmish; Elena Y Demireva; Jay A Gingrich
Journal:  Gene Expr Patterns       Date:  2016-11-04       Impact factor: 1.224

3.  The Nucleus Reuniens of the Midline Thalamus Gates Prefrontal-Hippocampal Modulation of Ventral Tegmental Area Dopamine Neuron Activity.

Authors:  Eric C Zimmerman; Anthony A Grace
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

4.  Distinct Roles of Dopamine Receptors in the Lateral Thalamus in a Rat Model of Decisional Impulsivity.

Authors:  Zhiyan Wang; Shengxiang Liang; Shuangshuang Yu; Tong Xie; Baicheng Wang; Junkai Wang; Yijing Li; Baoci Shan; Cailian Cui
Journal:  Neurosci Bull       Date:  2017-06-05       Impact factor: 5.203

Review 5.  Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.

Authors:  Marco Onofrj; Alberto J Espay; Laura Bonanni; Stefano Delli Pizzi; Stefano L Sensi
Journal:  Mov Disord       Date:  2019-07-15       Impact factor: 10.338

Review 6.  Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.

Authors:  Fabio Ferrarelli; Giulio Tononi
Journal:  Schizophr Res       Date:  2016-06-04       Impact factor: 4.939

7.  Maternal immune activation alters glutamic acid decarboxylase-67 expression in the brains of adult rat offspring.

Authors:  Sarah N Cassella; Ann M Hemmerle; Kerstin H Lundgren; Tara L Kyser; Rebecca Ahlbrand; Stefanie L Bronson; Neil M Richtand; Kim B Seroogy
Journal:  Schizophr Res       Date:  2016-01-29       Impact factor: 4.939

Review 8.  Sleep disturbances in schizophrenia: what we know, what still needs to be done.

Authors:  Rachel E Kaskie; Fabio Ferrarelli
Journal:  Curr Opin Psychol       Date:  2019-09-27

Review 9.  Thalamic inhibitory circuits and network activity development.

Authors:  Yasunobu Murata; Matthew T Colonnese
Journal:  Brain Res       Date:  2018-10-23       Impact factor: 3.252

10.  Corticothalamic gating of population auditory thalamocortical transmission in mouse.

Authors:  Baher A Ibrahim; Caitlin A Murphy; Georgiy Yudintsev; Yoshitaka Shinagawa; Matthew I Banks; Daniel A Llano
Journal:  Elife       Date:  2021-05-24       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.